A surgical treatment commonly used to reduce epileptic seizures in adults also is effective and safe for children, according to a new study. The study is one of the first to investigate responsive ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc., a Silicon Valley-based medical technology company that developed the world’s first and only closed-loop brain-responsive neurostimulation ...

On June 18, neurosurgeons at the University of Alabama at Birmingham implanted a new type of electrical stimulator to control seizures in patients with difficult-to-control epilepsy. It marked the ...

A University of Alabama at Birmingham pediatric neurosurgeon has performed the first deep brain stimulation (DBS) procedure for epilepsy at Children’s of Alabama (COA), offering a new treatment option ...

NEW ORLEANS--(BUSINESS WIRE)--American Epilepsy Society Annual Meeting, Booth 519—NeuroPace, Inc., a Silicon Valley-based medical technology company that recently launched the Next-Gen RNS ® System ...

GOOD LUCK TO YOU TONIGHT. A NEW WAY TO HEAL. THE MOST COMMON CHRONIC BRAIN DISEASE IN THE U.S. EPILEPSY. NEARLY 3 MILLION PEOPLE HAVE IT CAUSING DISRUPTIVE AND DANGEROUS SEIZURES. BUT NOW THERE IS A ...

A study of the long-term effectiveness of the first direct brain responsive neurostimulator for partial onset, or focal, seizures that cannot be controlled with medication demonstrates that responsive ...

NeuroPace, Inc. today announced that results from its pivotal trial demonstrated the RNS® System, a novel investigational device that utilizes responsive brain neurostimulation, significantly reduced ...

Vagus nerve stimulation. The vagus nerve stimulator received FDA approval in 1997 for the treatment of patients older than 12 years with refractory partial seizures. Overall, 39% of patients achieve ...

Despite the current arsenal of more than 20 antiepileptic drugs, approximately 35% of people with epilepsy continue to experience seizures. [1] For most of these patients, treatment consists of ...